APG-808 is under clinical development by Apogee Therapeutics and currently in Phase I for Unspecified Immunological Disorders.

Pegtarazimod is under clinical development by ReAlta Life Sciences and currently in Phase I for Coronavirus Disease 2019 (COVID-19) Associated Acute Lung Injury.

In 2021,138,825 people died from COPD in the U.S., making it the sixth overall leading cause of death and the fifth ...

China is grappling with an outbreak of the human metapneumovirus (HMPV), five years after the onset of the Covid-19 ...

Bangladesh's populous capital, Dhaka, ranked at the top of the list of cities with polluted air, with an AQI score of 358 at ...

The spread of HMPV in China has caused scare among people worldwide. Social media shows pictures of overwhelming number of patients in China. As the virus is being compared with the Covid-19, let us ...

These are the biggest signs that your cough is getting better according to Dr. Barrantes-Perez: “Symptoms also may not be as ...

Those who are diabetic or at high risk of diabetes should see their doctors twice a year. Those with uncontrolled diabetes ...